Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geraldine Rauch

Showing results (21-30 of 128) with videos related to

Pageof 13
Sort By:
Pharmaceutical Statistics|May 23, 2022
Optimal unplanned design modification in adaptive two-stage trialsMaximilian Pilz, Carolin Herrmann, Geraldine Rauch, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|May 9, 2019
[The role of biostatistics in institutional review boards]Peter Schlattmann, André Scherag, Geraldine Rauch, et al.
Biometrical Journal. Biometrische Zeitschrift|April 15, 2022
Optimization of adaptive designs with respect to a performance scoreCarolin Herrmann, Meinhard Kieser, Geraldine Rauch, et al.
BMJ Open|September 20, 2013
Phase I trial of concurrent sunitinib and radiation therapy as preoperative treatment for soft tissue sarcomaJens Jakob, Geraldine Rauch, Frederik Wenz, et al.
BMJ Open|February 7, 2020
Comprehensive survey among statistical members of medical ethics committees in Germany on their personal impression of completeness and correctness of biostatistical aspects of submitted study protocolsGeraldine Rauch, Lorena Hafermann, Ulrich Mansmann, et al.
World Journal of Cardiology|January 30, 2015
Opportunities and challenges of clinical trials in cardiology using composite primary endpointsGeraldine Rauch, Bernhard Rauch, Svenja Schüler, et al.
Statistics in Medicine|April 7, 2020
A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculationCarolin Herrmann, Maximilian Pilz, Meinhard Kieser, et al.
Biometrical Journal. Biometrische Zeitschrift|August 12, 2024
Sample Size Calculation Under Nonproportional Hazards Using Average Hazard RatiosIna Dormuth, Markus Pauly, Geraldine Rauch, et al.
Statistics in Medicine|October 15, 2013
Opportunities and challenges of combined effect measures based on prioritized outcomesGeraldine Rauch, Antje Jahn-Eimermacher, Werner Brannath, et al.
Journal of Biopharmaceutical Statistics|December 28, 2021
On the feasibility of pediatric dose-finding trials in small samples with information from a preceding trial in adultsDario Zocholl, Manuel Wiesenfarth, Geraldine Rauch, et al.
Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
Pharmaceutical Statistics|May 23, 2022
Optimal unplanned design modification in adaptive two-stage trialsMaximilian Pilz, Carolin Herrmann, Geraldine Rauch, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|May 9, 2019
[The role of biostatistics in institutional review boards]Peter Schlattmann, André Scherag, Geraldine Rauch, et al.
Biometrical Journal. Biometrische Zeitschrift|April 15, 2022
Optimization of adaptive designs with respect to a performance scoreCarolin Herrmann, Meinhard Kieser, Geraldine Rauch, et al.
BMJ Open|September 20, 2013
Phase I trial of concurrent sunitinib and radiation therapy as preoperative treatment for soft tissue sarcomaJens Jakob, Geraldine Rauch, Frederik Wenz, et al.
BMJ Open|February 7, 2020
Comprehensive survey among statistical members of medical ethics committees in Germany on their personal impression of completeness and correctness of biostatistical aspects of submitted study protocolsGeraldine Rauch, Lorena Hafermann, Ulrich Mansmann, et al.
World Journal of Cardiology|January 30, 2015
Opportunities and challenges of clinical trials in cardiology using composite primary endpointsGeraldine Rauch, Bernhard Rauch, Svenja Schüler, et al.
Statistics in Medicine|April 7, 2020
A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculationCarolin Herrmann, Maximilian Pilz, Meinhard Kieser, et al.
Biometrical Journal. Biometrische Zeitschrift|August 12, 2024
Sample Size Calculation Under Nonproportional Hazards Using Average Hazard RatiosIna Dormuth, Markus Pauly, Geraldine Rauch, et al.
Statistics in Medicine|October 15, 2013
Opportunities and challenges of combined effect measures based on prioritized outcomesGeraldine Rauch, Antje Jahn-Eimermacher, Werner Brannath, et al.
Journal of Biopharmaceutical Statistics|December 28, 2021
On the feasibility of pediatric dose-finding trials in small samples with information from a preceding trial in adultsDario Zocholl, Manuel Wiesenfarth, Geraldine Rauch, et al.
Pageof 13